DOD Biotech PCL (BKK:DOD) Total Equity: ฿935.0 Mil (As of Mar. 2026)


BKK:DOD DOD Biotech PCL BKK:DOD
77 GF Score
Price ฿1.16
GF Value ฿1.67
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is DOD Biotech PCL Total Equity?

DOD Biotech PCL BKK:DOD -1.69% 77 Total Equity is ฿935.0 Mil as of Mar. 2026. GuruFocus rates BKK:DOD with a GF Score™ of 77/100 and a GF Value™ of ฿1.67 (Possible Value Trap). The stock has 5 warning signs investors should review.

DOD Biotech PCL's total equity for the quarter that ended in Mar. 2026 was ฿935.0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

DOD Biotech PCL Total Equity Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Total Equity Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,262.30 893.63 1,080.06 891.91 953.84

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 922.13 930.85 941.11 953.84 935.02
BKK:DOD
77GF Score
DOD Biotech PCL BKK:DOD
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

DOD Biotech PCL's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1153.968-200.127
=953.8

DOD Biotech PCL's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1129.846-194.829
=935.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ฿935.0 Mil mean?
DOD Biotech PCL (BKK:DOD) has a Total Equity of ฿935.0 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's Total Equity too high?
DOD Biotech PCL's current Total Equity is ฿935.0 Mil. Overall, DOD Biotech PCL has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Total Equity compare to KHC and GIS?
DOD Biotech PCL's Total Equity of ฿935.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for DOD Biotech PCL and its competitors. DOD Biotech PCL's current Total Equity is ฿935.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Possible Value Trap. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.16 — trading 30.5% below its estimated fair value. The current Total Equity is ฿935.0 Mil. DOD Biotech PCL's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Total Equity is ฿935.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.16 is trading 30.5% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Possible Value Trap.

Key valuation signals for BKK:DOD:

  • Total Equity: ฿935.0 Mil
  • GF Value™: ฿1.67 vs. price of ฿1.16 (30.5% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
77GF Score

Get the complete analysis for BKK:DOD

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.16
Price
฿1.67
GF Value